The Top Line

December 2, 2022


Listen Later

Biogen recently named Christopher Viehbacher its new CEO, ending a monthslong search to replace Michel Vounatsos. Fraiser Kansteiner and Kevin Dunleavy talk about the current state of the company and recent investor reactions to the new hire. Plus, they discuss a string of other biopharma CEO appointments. 

And, in this episode, we cover the week's news including what Albert Bourla, Ph.D., said that has him in hot water along with a $3.5 million drug, and we tease a possible major acquisition. 

To learn more about topics in this episode:

  • Biogen's incoming CEO Viehbacher gets mixed reviews—and lots of advice—in investor survey 
  • Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line 
  • Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal 
  • Facing a familiar side effect problem, Eisai makes the case for its next Alzheimer's drug after patient deaths
  • Amgen, J&J and Sanofi size up Horizon as Big Pharma renews interest in rare disease M&A 
  • Pfizer CEO Bourla stung by UK's pharma marketing regulator over kids' COVID vax claims: report 
  • GE Healthcare unveils AI program bundle for simplified MRI scans
  • Philips unveils AI-powered platform to improve diagnoses from imaging scans

"The Top Line" is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

See omnystudio.com/listener for privacy information.

...more
View all episodesView all episodes
Download on the App Store

The Top LineBy Fierce Life Sciences

  • 4.1
  • 4.1
  • 4.1
  • 4.1
  • 4.1

4.1

12 ratings


More shows like The Top Line

View all
Motley Fool Hidden Gems Investing by The Motley Fool

Motley Fool Hidden Gems Investing

3,228 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,713 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,420 Listeners

Masters in Business by Bloomberg

Masters in Business

2,175 Listeners

The McKinsey Podcast by McKinsey & Company

The McKinsey Podcast

386 Listeners

Odd Lots by Bloomberg

Odd Lots

1,993 Listeners

Trumponomics by Bloomberg

Trumponomics

355 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,649 Listeners

HBR IdeaCast by Harvard Business Review

HBR IdeaCast

154 Listeners

FT Tech Tonic by Financial Times

FT Tech Tonic

96 Listeners

Masters of Scale by WaitWhat

Masters of Scale

3,992 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,448 Listeners

The Readout Loud by STAT

The Readout Loud

337 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

HBR On Leadership by Harvard Business Review

HBR On Leadership

170 Listeners